All posts
Published
September 11, 2025

Healthcare Investment: A Path to Economic Prosperity in the Global South

Spyeside team analyzes how investing in healthcare and establishing universal access pathways is crucial for accelerating societal and economic growth, especially in resource-constrained environments. Examples from the Global South demonstrate that universal coverage reforms and essential benefits packages not only improve health equity but also accelerate and sustain economic growth long-term.

Spyeside team analyzes how investing in healthcare and establishing universal access pathways is crucial for accelerating societal and economic growth, especially in resource-constrained environments. Examples from the Global South demonstrate that universal coverage reforms and essential benefits packages not only improve health equity but also accelerate and sustain economic growth long-term.

A healthy workforce and population are fundamental to a thriving economy. While the upfront costs of establishing universal healthcare can seem daunting for nations in the Global South, the long-term benefits are undeniable. By improving health outcomes and ensuring access to essential medicines, countries can unlock significant economic potential. This is a strategic investment in human capital that pays dividends in productivity, stability, and sustainable growth.

The Role of Universal Healthcare Schemes & Essential Medicines

Many countries have successfully leveraged policy changes to expand healthcare access. The introduction of Universal Healthcare Schemes (UHS) and National Lists of Essential Medicines (NLEM) are powerful examples. These policies provide a baseline level of care, ensuring that cost-effective medicines are accessible to a wider population. The key to making these initiatives effective lies in linking evidence to policy and medical practice. This is where Health Technology Assessments (HTA) become a game-changer.

Linking Policy to Growth: Key Examples

Thailand is a prime example. Since its establishment in 2007, the HTA body, HITAP, has institutionalized evidence-based practices. By linking health economics to policy, HITAP's recommendations have expanded the NLEM, which serves as the national reimbursement list. This has facilitated coverage for over 95% of Thailand's population under three public health schemes, directly supporting the nation's development goals. (Teerawattananona et.al, 2024)

Vietnam has adopted a similar approach, incorporating HTA outcomes into health insurance decisions since 2014. This strategy has been instrumental in expanding public health services, keeping pace with rapid economic growth and the increasing demands of the labor market. (Lee et.al, 2021).

In Latin America, countries like Brazil (Ortega et.al., 2023) have seen steady gains toward universal coverage through its Unified Health System, even amid fiscal austerity. Colombia (Vergara et.al., 2024) has moved toward a unified, implicitly defined benefits approach. Research in both countries has shown that when benefits policy, payment, and regulation evolve together, access expands, leading to health improvements that accumulate and support human capital formation.

Conclusion

These case studies from Asia and Latin America underscore a critical lesson: universal healthcare and essential benefits are not just social programs; they are vital economic accelerators. By adopting evidence-based frameworks like HTAs, countries in the Global South can make informed decisions that improve health equity and build a stronger, more resilient economy for the future.

Recent News

View All News
Reputation Management

Reputation Gets Built Long Before the Headline

Speyside Group provides an overview on reputation risk. The analysis sets out three connected disciplines: continuous mapping of inward and outward risk, stakeholder engagement built relationship by relationship rather than aimed at a general public, and issue management.
Read post
Healthcare

What Is Compassionate Use and How Does It Work in Latin America, Africa and Asia?

Speyside Group provides a strategic perspective on compassionate use regulations across Latin America, Africa, and Asia, mapping how patients with serious or life-threatening conditions access unapproved medicines outside a clinical trial. The analysis compares Brazil's RDC 38/2013, South Africa's Section 21, and Asia's more codified frameworks, and outlines the practical questions multinational pharmaceutical companies must answer before running a program in any given market.
Read post
Healthcare

How do pharma companies engage healthcare policy in Latin America?

Speyside Group provides a strategic perspective on how pharmaceutical companies influence healthcare policy in Latin America, mapping the seven principal channels of engagement across the region's leading regulatory and reimbursement bodies. Drawing on CONITEC data, Brazil's Partnerships for Productive Development, and coalition-building work with groups such as ERCAL and ILAR, the analysis shows why evidence generation and multi-stakeholder consensus consistently outperform formal lobbying in this market.
Read post